Landsberg Bennett & Dubbaneh’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$367K Sell
588
-34
-5% -$22.8K 0.05% 205
2021
Q2
$396K Buy
622
+83
+15% +$45.8K 0.05% 191
2021
Q1
$262K Buy
+539
New +$270K 0.04% 234

Other funds holding IDXX

Landsberg Bennett & Dubbaneh's IDXX Position: Q3 2021 in Review

Landsberg Bennett & Dubbaneh reduced its Idexx Laboratories (IDXX) stake by 5.5% in Q3 2021, selling an estimated $22.8K and leaving 588 shares worth $367K. The position accounts for 0.05% of the portfolio, ranked #205.

Landsberg Bennett & Dubbaneh first reported a position in IDXX in Q1 2021 and has held it in 3 quarters since. The position peaked at $396K in Q2 2021. 1,059 funds tracked by Wall St. Rank hold IDXX as of Q3 2021.

  • Landsberg Bennett & Dubbaneh held 588 shares of Idexx Laboratories worth $367K as of Q3 2021.
  • Landsberg Bennett & Dubbaneh sold 34 Idexx Laboratories shares in Q3 2021, an estimated $22.8K.
  • Idexx Laboratories made up 0.05% of Landsberg Bennett & Dubbaneh's portfolio in Q3 2021, its #205 holding.
  • Landsberg Bennett & Dubbaneh first reported a position in Idexx Laboratories in Q1 2021 and has held it in 3 quarters since.
  • Landsberg Bennett & Dubbaneh's Idexx Laboratories position peaked at $396K in Q2 2021.
  • 1,059 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2021.

Based on Landsberg Bennett & Dubbaneh's 13F filing for Q3 2021, filed 29 Oct 2021.